Citations

Clear

5212 citation(s) found for "Wang, Li-Ju".

Characteristics and outcomes of incidentally diagnosed diffuse large B‐cell lymphoma and implications for cancer screening
Atallah‐Yunes, Suheil Albert , Mwangi, Raphael , Kuchler, Robyn L., Nowakowski, Grzegorz S. , Habermann, Thomas M. , Wang, Yucai , Thompson, Carrie A. , Maurer, Matthew J. , Ansell, Stephen M. , Rees, Matthew James , Habermann, Thomas , Wang, Yucai , Maurer, Matthew , Cerhan, James R , Ansell, Stephen M , Witzig, T.E. , Atallah-Yunes, Albert , Rees, Matthew J. , Kuchler, Robyn L. , Feldman, Andrew L. , Cerhan, James R. , Witzig, Thomas E.

Mayo Clinic

American Journal of Hematology | October 14, 2024 | Volume: 100 | Issue: 1 | Pages: 158-162

10.1002/ajh.27504 | PMID 39400430 Get It

Comparing Recurrence Rates and the Cost-Effectiveness of Arthroscopic Labral Repair and Nonoperative Management for Primary Anterior Shoulder Dislocations in Young Patients: A Decision-Analytic Markov Model-Based Analysis
Oeding, Jacob F. , Schulz, William R., Wang, Allen S. , Krych, Aaron J. , Taylor, Dean C. , Samuelsson, Kristian , Camp, Christopher L. , Krych, Aaron J , Wang, Allen , Samuelsson, Kristian , Oeding, Jacob F , Schulz, William R., Tagliero, Adam J.

Mayo Clinic

The American Journal of Sports Medicine | October 12, 2024 | Volume: 52 | Issue: 13 | Pages: 3339-3348

10.1177/03635465241282342 | PMID 39394775 Get It

Background: Value-based decision-making regarding nonoperative management versus early surgical stabilization for first-time anterior shoulder instability (ASI) events remains understudied. Purpose: To perform (1) a systematic review of the current literature and (2) a Markov model–based cost-effectiveness analysis comparing an initial trial of nonoperative management to arthroscopic Bankart repair (ABR) for first-time ASI. Study Design: Economic and decision analysis; Level of evidence, 3. Methods: A Markov chain Monte Carlo probabilistic model was developed to evaluate the outcomes and costs of 1000 simulated patients (mean age, 20 years; range, 12-26 years) with first-time ASI undergoing nonoperative management versus ABR. Utility values, recurrence rates, and transition probabilities were derived from the published literature. Costs were determined based on the typical patient undergoing each treatment strategy at the authors’ institution. Outcome measures included costs, quality-adjusted life-years (QALYs), and the incremental cost-effectiveness ratio (ICER). Results: The Markov model with Monte Carlo microsimulation demonstrated mean (± standard deviation) 10-year costs for nonoperative management and ABR of $38,649 ± $10,521 and $43,052 ± $9352, respectively. Total QALYs acquired over the 10-year time horizon were 7.67 ± 0.43 and 8.44 ± 0.46 for nonoperative management and ABR, respectively. The ICER comparing ABR with nonoperative management was found to be just $5725/QALY, which falls substantially below the $50,000 willingness-to-pay (WTP) threshold. The mean numbers of recurrences were 2.55 ± 0.31 and 1.17 ± 0.18 for patients initially assigned to the nonoperative and ABR treatment groups, respectively. Of 1000 samples run over 1000 trials, ABR was the optimal strategy in 98.7% of cases, with nonoperative management the optimal strategy in 1.3% of cases. Conclusion: ABR reduces the risk for recurrent dislocations and is more cost-effective despite higher upfront costs when compared with nonoperative management for first-time ASI in the young patient. While all these factors are important to consider in surgical decision-making, ultimate treatment decisions should be made on an individual basis and occur through a shared decision-making process.
High-Density Lipoprotein Mimetic Peptide 4F Reduces Toxic Amyloid-Beta Exposure to the Blood-Brain Barrier Endothelium in Alzheimer’s Disease Transgenic Mice
Wang, Zengtao , Zhong, Rui , Curran, Geoffry L., Min, Hoon‐Ki , Lowe, Val J. , Kandimalla, Karunya K. , Min, Paul, Kandimalla, Karunya K , Min, Hoon-Ki Paul , Li, Ling

Mayo Clinic

Molecular Pharmaceutics | October 12, 2024 | Volume: 21 | Issue: 11 | Pages: 5661-5671

10.1021/acs.molpharmaceut.4c00633 | PMID 39394037 Get It

Incidence of revision surgery and patient-reported outcomes within 5 years of the index procedure for grade 1 spondylolisthesis: an analysis from the Quality Outcomes Database spondylolisthesis data
Birlingmair, Jacob, Djurasovic, Mladen, Mummaneni, Praveen V. , Asher, Anthony L. , Bisson, Erica F. , Bydon, Mohamad , Chan, Andrew K. , Chou, Dean , Coric, Domagoj , Foley, Kevin T. , Fu, Kai-Ming, Haid, Regis W., Knightly, John J. , Le, Vivian , Potts, Eric A. , Shaffrey, Christopher I. , Shaffrey, Mark E., Slotkin, Jonathan R., Virk, Michael S. , Wang, Michael Y. , Glassman, Steven D. , Carreon, Leah Y. , Park, Paul

Mayo Clinic

Journal of Neurosurgery: Spine | October 12, 2024 | Volume: No volume available | Issue: No issue available | Pages: 1-6

10.3171/2024.6.spine24488 | PMID 39393106 Get It

OBJECTIVE Some patients treated surgically for grade 1 spondylolisthesis require revision surgery. Outcomes after revision surgery are not well studied. The objective of this study was to determine how revision surgery impacts patient-reported outcomes (PROs) in patients undergoing decompression only or decompression and fusion (D+F) for grade 1 spondylolisthesis within 5 years of the index surgery. METHODS Patients in the 12 highest Quality Outcomes Database (QOD) enrolling sites with a diagnosis of grade 1 spondylolisthesis were identified and the incidence of revision surgery between the decompression-only and D+F patients were compared. PROs were compared between cohorts requiring revision surgery versus a single index procedure. RESULTS Of 608 patients enrolled, 409 had complete 5-year data available for this study. Eleven (13.3%) of 83 patients underwent revision in the decompression-only group as well as 32 (9.8%) of 326 in the D+F group. For the entire cohort, patients requiring revision had significantly worse PROs at 5 years: Oswestry Disability Index (ODI) 27.4 versus 19.4, p = 0.008; numeric rating scale for back pain (NRS-BP) 4.1 versus 3.0, p = 0.013; and NRS for leg pain (NRS-LP) 3.4 versus 2.1, p = 0.029. In the decompression-only group, the change in 5-year PROs was not impacted by revision status: ODI 31.9 versus 24.2, p = 0.287; NRS-BP 1.9 versus 2.9, p = 0.325; and NRS-LP 6.2 versus 3.7, p = 0.011. In the D+F group, the change in 5-year PROs was diminished if patients required revision: ODI 19.1 versus 29.1, p = 0.001; NRS-BP 3.0 versus 4.0, p = 0.170; and NRS-LP 2.3 versus 4.6, p = 0.001. CONCLUSIONS The most common reasons for reoperation within 5 years in the decompression-only group were repeat decompression and instability, whereas in the D+F group the most common reason was adjacent-segment disease. The need for revision resulted in modestly diminished benefit compared with patients with no revisions. These differences were greater in the fusion cohort compared with the decompression-only cohort. The mean PRO improvement still far exceeded minimal clinically important difference thresholds for all measures for patients who underwent a revision surgery.
Efficacy and safety of inebilizumab in patients aged 50 years and older with neuromyelitis optica spectrum disorder: N-MOmentum study subgroup analysis
Kanegae, Marilia Pyles Patto, Mao‐Draayer, Yang , Wingerchuk, Dean M. , Paul, Friedemann, Cimbora, D., Patterson, Kristina R. , Graves, Jennifer , Kunchok, Amy , Lackey, Elijah , Paul, Friedemann , Fujihara, Kazuo , Sato, Douglas Kazutoshi , Wang, Zhong, Cimbora, Daniel , Cree, Bruce

Mayo Clinic

Arquivos de Neuro-Psiquiatria | October 11, 2024 | Volume: 82 | Issue: S 01 | Pages: S1-S52

10.1055/s-0044-1789431 Get It

Somatic mosaicism in schizophrenia brains reveals prenatal mutational processes
Maury, Eduardo A. , Jones, Attila , Seplyarskiy, Vladimir , Nguyen, Thanh Thanh L. , Rosenbluh, Chaggai , Bae, Taejong, Wang, Yifan , Abyzov, Alexej , Khoshkhoo, Sattar , Chahine, Yasmine, Zhao, Sijing , Venkatesh, Sanan , Root, Elise, Voloudakis, Georgios , Roussos, Panagiotis , Network‡, Brain Somatic Mosaicism, Brennand, Kristen , Reilly, Steven K. , Sunyaev, Shamil , Chess, Andrew , Bae, Taejeong , Moran, John V. , Zhou, Weichen , Zhu, Xiaowei , Bizzotto, Sara , Galor, Alon , Yang, Xiaoxu , Bae, Taejeong , Park, Peter J , Akbarian, Schahram , Brennand, Kristen , Reilly, Steven , Lee, Eunjung A , Sunyaev, Shamil R , Walsh, Christopher A , Chess, Andrew , Nguyen, Thanh Thanh L. , Abyzov, Alexej , Wang, Yifan , Voloudakis, Georgios , Maury, Eduardo A. , Jones, Attila , Seplyarskiy, Vladimir , Root, Elise , Network‡, Brain Somatic Mosaicism, Park, Peter J. , Akbarian, Schahram , Walsh, Christopher A.

Mayo Clinic

Science | October 10, 2024 | Volume: 386 | Issue: 6718 | Pages: 217-224

10.1126/science.adq1456 | PMID 39388546 Get It

Germline mutations modulate the risk of developing schizophrenia (SCZ). Much less is known about the role of mosaic somatic mutations in the context of SCZ. Deep (239×) whole-genome sequencing (WGS) of brain neurons from 61 SCZ cases and 25 controls postmortem identified mutations occurring during prenatal neurogenesis. SCZ cases showed increased somatic variants in open chromatin, with increased mosaic CpG transversions (CpG>GpG) and T>G mutations at transcription factor binding sites (TFBSs) overlapping open chromatin, a result not seen in controls. Some of these variants alter gene expression, including SCZ risk genes and genes involved in neurodevelopment. Although these mutational processes can reflect a difference in factors indirectly involved in disease, increased somatic mutations at developmental TFBSs could also potentially contribute to SCZ.
Genomic imprinting biomarkers for cervical cancer risk stratification
Bai, Peng, Chen, Ying , Qin, Zhengwen, Cheng, Tong , Pineda, John , Shi, Panying, Wang, Xiaonan , Wang, Jianhong, Xu, Lian , Zheng, Huixian, Lin, Wenyi , Huang, Wenbin , Shen, Rulong , Yue, Changjun, Xu, Hui‐Xiong , Zhou, Ning , Zhang, Yaoyao , Liu, Hanmin , Xiao, Xue , Wang, Wei , Xing, Li , Wang, Xiaonan, Gao, Xuemei , Yang, Lulu , Batalini, Felipe , Liu, Yang

Mayo Clinic

Cancer Communications | October 10, 2024 | Volume: 44 | Issue: 12 | Pages: 1385-1390

10.1002/cac2.12617 | PMID 39388677 Get It

A Multicenter Analysis of 3 Decades of Hip Arthroscopy: Evolving Techniques and Growing Patient Volumes From 1988 to 2022
Conyer, Ryan T. , Cleary, Emmett J., Wang, Allen S. , Boos, Alex M., Crowe, Matthew M. , Krych, Aaron J. , Levy, Bruce A. , Hevesi, Mario , Boos, Alexander M. , Economopoulos, Kostas J. , Krych, Aaron J , Hevesi, Mario , Wang, Allen , Boos, Alexander

Mayo Clinic

Orthopaedic Journal of Sports Medicine | October 10, 2024 | Volume: 12 | Issue: 10 | Pages: No page available

10.1177/23259671241277793 | PMID 39399769 Get It

Background: The number of hip arthroscopies performed in the United States has grown significantly over the past several decades, with evolving indications and emerging techniques. Purposes: To (1) examine the evolution of hip arthroscopy at 3 tertiary referral centers between 1988 and 2022 and (2) quantify trends in patient demographics and procedures performed. Study Design: Case series; Level of evidence, 4. Methods: A retrospective analysis was performed of all patients undergoing hip arthroscopy at 3 academic centers between 1988 and 2022. Demographic data were collected using standardized forms and operative notes, and intraoperative images were manually reviewed for each patient to determine the specific procedures performed at the time of the hip arthroscopy. Surgical procedures were plotted over time to evaluate trends. Patients were divided into 3 time periods for comparison: early hip arthroscopy from 1988 to 2008, 2009 (the time of the first labral repair in our cohort) to 2015, and 2016 to 2022. Results: A total of 3000 patients (age, 35.7 ± 13.8 years; age range, 10-89 years; female sex, 2109 (70.3%); body mass index, 27.4 ± 6.3 kg/m 2 ) underwent arthroscopic hip procedures between 1988 and 2022. The mean number of cases increased from a mean of 3.2 per year in 1988-2008 to 285.9 per year in 2016-2022 ( P < .001). Labral treatment at the time of primary hip arthroscopy evolved from 100% debridement and 0% repair in 1988-2008 to 5.0% debridement, 94.0% repair, and 1.0% labral reconstruction in 2016-2022 ( P < .001). Cam resection increased from 4.1% in 1988-2008 to 86.9% in 2016-2022 ( P < .001). By 2022, 45 out of 325 cases (13.8%) were revisions. The rate of capsular repair at the time of primary hip arthroscopy increased from 0.0% in 1988-2008 up to 81.0% in 2016-2022. Conclusion: There has been a significant growth of hip arthroscopy volumes as well as a significant transition from use as a tool for diagnosis and labral debridement to procedures restoring native anatomy including labral repair, cam resection, capsular repair, periacetabular osteotomy, and gluteal repair.
Pain and Suffering: AJR Podcast Series on Wellness, Episode 7
Wang, Sherry S.

Mayo Clinic

American Journal of Roentgenology | October 9, 2024 | Volume: 223 | Issue: 5 | Pages: No page available

10.2214/ajr.24.32153 | PMID 39382532 Get It